medigraphic.com
ISSN 0326-3428 (Print)
Órgano de difusión científica de la Asociación Nefrológica de Buenos Aires

2023, Number 2

<< Back Next >>

Rev Nefrol Dial Traspl 2023; 43 (2)

Prevalence of hyperkalemia associated risk factors and morbidity and mortality in patients on hemodialysis

Roatta V, Laham G, Rodríguez LM, Abib A

Language: Spanish
References: 8
Page: 79-86
PDF size: 476.91 Kb.


ABSTRACT

Introduction: Sudden death is the leading cause of death in patients with CKD on chronic hemodialysis (HD). Objective: To evaluate the prevalence of hyperkalemia (HK) in patients treated with HD, the risk factors associated with its development, and to determine its association with all-cause mortality and cardiovascular mortality. Materials and methods: Retrospective cohort study including 153 HD patients. Serum K (potassium) was recorded from November 2020 for six months in a short interdialytic period. Results: The prevalence of HK (K›5.1) was 35.3% (n=54). When comparing hyperkalemic (HK) vs. normokalemic (NK) patients, we found significant age differences (61 vs. 68 years p: 0.013), time on dialysis (83 vs. 51 months p= 0.002), vascular access (AVF/prosthesis) (88.9 vs. 67.7% p= 0.016) and use of K chelators (20.4 vs. 4% p= 0.003), with a tendency to significance in the Charlson score (5 vs. 6 p= 0.07). In the multivariate analysis, the Charlson Score (OR: 1.36, CICI 1.19-1.55, p ‹0.001) and hospitalizations (OR: 5, CI 2.18- 11.68, p ‹0.001) were associated with higher mortality, while HK remained as a protective factor (OR: 0.287, CI 0.124%E2%80%930.664 p: 0.004). Conclusion: HK was associated with lower age and Charlson scores than NK. HK was significantly associated with lower all-cause mortality.


REFERENCES

  1. Karaboyas A, Zee J, Brunelli SM, Usvyat LA, WeinerDE, Maddux FW, Nissenson AR, Jadoul M, LocatelliF, Winkelmayer WC, Port FK, Robinson BM, TentoriF. Dialysate Potassium, Serum Potassium, Mortality,and Arrhythmia Events in Hemodialysis: Results fromthe Dialysis Outcomes and Practice Patterns Study(DOPPS). Am J Kidney Dis. 2017 Feb;69(2):266-277.doi: 10.1053/j.ajkd.2016.09.015. Epub 2016 Nov 17.PMID: 27866964; PMCID: PMC5520979.

  2. Registro Argentino de Diálisis Crónica 2020 Informe2021-Instituto Nacional Central Único Coordinadorde Ablación e Implante (INCUCAI) SociedadArgentina de Nefrología (SAN)

  3. Angelo Karaboyas, Bruce M Robinson, Glen James,Katarina Hedman, Carol P Moreno Quinn, PatriciaDe Sequera, Kosaku Nitta, Roberto Pecoits-Filho,Hyperkalemia excursions are associated with anincreased risk of mortality and hospitalizations inhemodialysis patients, Clinical Kidney Journal, Volume14, Issue 7, July 2021, Pages 1760–1769, https://doi.org/10.1093/ckj/sfaa208

  4. María Jesús Puchades, José Luis Górriz. Epidemiologíade la hiperpotasemia. Sociedad Española de Nefrología.Revista Nefrologia. Monogr. Nefrol. 2019;1(1):3-9.

  5. Bem D, Sugrue D, Wilding B, Zile I, Butler K, BoothD, Tafesse E, McEwan P. The effect of hyperkalemiaand long inter-dialytic interval on morbidity andmortality in patients receiving hemodialysis: asystematic review. Ren Fail. 2021 Dec;43(1):241-254. doi: 10.1080/0886022X.2020.1871012. PMID:33478329; PMCID: PMC7833048.

  6. Yusuf AA, Hu Y, Singh B, Menoyo JA, Wetmore JB.Serum Potassium Levels and Mortality in HemodialysisPatients: A Retrospective Cohort Study. Am J Nephrol.2016;44(3):179-86. doi: 10.1159/000448341. Epub2016 Sep 3. PMID: 27592170.

  7. Dashputre AA, Potukuchi PK, Sumida K, Kar S, ObiY, Thomas F, Molnar MZ, Streja E, Kalantar-ZadehK, Kovesdy CP. Predialysis Potassium Variability andPostdialysis Mortality in Patients With AdvancedCKD. Kidney Int Rep. 2021 Jan 14;6(2):366-380.doi: 10.1016/j.ekir.2020.11.022. PMID: 33615062;PMCID: PMC7879127.

  8. Erdoğdu, Halil & Kara, Fatih. (2019). Residual KidneyFunction in Hemodialyzed Patients and RelatedFactors. Erciyes Tip Dergisi. 41. 327-332. 10.14744/etd.2019.22230.




2020     |     www.medigraphic.com